Cited by 1,345BRCA gene mutations in cancerCancer Genomics and DiagnosticsGenomics and Rare Diseases

The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.

Germline Mutations in Predisposition Genes in Pediatric Cancer

Open access

Zhang, Jinghui, Walsh, Michael F., Wu, Gang, Edmonson, Michael N., Gruber, Tanja A., Easton, John, Hedges, Dale, Ma, Xiaotu, Zhou, Xin, Yergeau, Donald A., Wilkinson, Mark R., Vadodaria, Bhavin, Chen, Xiang, McGee, Rose B., Hines-Dowell, Stacy, Nuccio, Regina, Quinn, Emily, Shurtleff, Sheila A., Rusch, Michael, Patel, Aman, Becksfort, Jared B., Wang, Shuoguo, Weaver, Meaghann S., Ding, Li, Mardis, Elaine R., Wilson, Richard K., Gajjar, Amar, Ellison, David W., Pappo, Alberto S., Pui, Ching-Hon, Nichols, Kim E., Downing, James R.·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1508054PMC PMC4734119

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The prevalence and spectrum of predisposing mutations among children and adolescents with cancer are largely unknown. Knowledge of such mutations may improve the understanding of tumorigenesis, direct patient care, and enable genetic counseling of patients and families. METHODS: In 1120 patients younger than 20 years of age, we sequenced the whole genomes (in 595 patients), whole exomes (in 456), or both (in 69). We analyzed the DNA sequences of 565 genes, including 60 that have been associated with autosomal dominant cancer-predisposition syndromes, for the presence of germline mutations. The pathogenicity of the mutations was determined by a panel of medical experts with the use of cancer-specific and locus-specific genetic databases, the medical literature, computational predictions, and second hits identified in the tumor genome. The same approach was used to analyze data from 966 persons who did not have known cancer in the 1000 Genomes Project, and a similar approach was used to analyze data from an autism study (from 515 persons with autism and 208 persons without autism). RESULTS: Mutations that were deemed to be pathogenic or probably pathogenic were identified in 95 patients with cancer (8.5%), as compared with 1.1% of the persons in the 1000 Genomes Project and 0.6% of the participants in the autism study. The most commonly mutated genes in the affected patients were TP53 (in 50 patients), APC (in 6), BRCA2 (in 6), NF1 (in 4), PMS2 (in 4), RB1 (in 3), and RUNX1 (in 3). A total of 18 additional patients had protein-truncating mutations in tumor-suppressor genes. Of the 58 patients with a predisposing mutation and available information on family history, 23 (40%) had a family history of cancer. CONCLUSIONS: Germline mutations in cancer-predisposing genes were identified in 8.5% of the children and adolescents with cancer. Family history did not predict the presence of an underlying predisposition syndrome in most patients. (Funded by the American Lebanese Syrian Associated Charities and the National Cancer Institute.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1508054

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Enhancements and modifications of primer design program Primer3
Kõressaar, T., & Remm, M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm091 · Cited by 2,618
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544
Principles and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,034
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citation

Flagged first, then by citations

Show all 56 references

2 of the 56 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Lindor NM, 2008, J Natl Cancer Inst Monogr, 1
Meldrum C, 2011, Clin Biochem Rev, 32, 177
Armes JE, 1999, Cancer Res, 59, 2011

Sorted by citations

Items 801–900 of 1,000

Germline variants in patients diagnosed with pediatric soft tissue sarcoma
Yndestad, S., Haugland, H. K., Goplen, D., Wojcik, D. M., Knappskog, S., & Lønning, P. E. (2024) · Acta Oncologica · doi:10.2340/1651-226x.2024.40730 · Cited by 4
A review calling for research directed at early detection of childhood cancers: The clinical, scientific, and economic arguments for population screening and surveillance
Apps, J. R., Ritzmann, T. A., Liu, J., Shanmugavadivel, D., Halsey, C., Pritchard‐Jones, K., Atun, R. A., Oliver, K. R., Vedhara, K., Ball-Gamble, A., et al. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100191 · Cited by 5
Germline mismatch repair gene mutations in children with tumors: a case series from two centers
Li, C., Liu, A. P. Y., Mo, S., Ambe, P. C., Chen, J., & Chan, G. (2024) · Translational Pediatrics · doi:10.21037/tp-24-343 · Cited by 4
An evaluation of genetic predisposition to congenital anomalies and pediatric cancer supports KAT6B as a novel neuroblastoma susceptibility gene
Gu, H., Yu, Y., Sisoudiya, S. D., Mishra, P., Li, H., Schraw, J. M., Scheurer, M. E., Muzny, D. M., Mitchell, D., Taylor, O. A., et al. (2024) · Genetics in Medicine Open · doi:10.1016/j.gimo.2024.101901 · Cited by 4
How to Screen for Hereditary Cancers in General Pathology Practice
Sheffield, B. S., Hirsch‐Reinshagen, V., & Schrader, K. A. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0457-ra · Cited by 4
Ganglioglioma, Epilepsy, and Intellectual Impairment due to Familial TSC1 Deletion
Gilboa, T., Segel, R., Zeligson, S., Alterescu, G., & Ben‐Pazi, H. (2018) · Journal of Child Neurology · doi:10.1177/0883073818767036 · Cited by 4
The Role of Precision Medicine in the Diagnosis and Treatment of Patients with Rare Cancers
Demeure, M. J. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-16391-4_3 · Cited by 4
Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy
Lavergne, V., Sabnis, A. J., Tupule, A., Davidson, P. R., Kline, C., Matthay, K. K., Nicolaides, T. P., Goldsby, R. E., Braunstein, S. E., Fogh, S. E., et al. (2019) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001668 · Cited by 4
Applications of probability and statistics in cancer genomics
Ma, X., Arunachalam, S., & Liu, Y. (2020) · Quantitative Biology · doi:10.1007/s40484-020-0203-8 · Cited by 3
Self-citation
Early Presentation of Homozygous Mismatch Repair Deficient Glioblastoma in Teen With Lynch Syndrome: Implications for Treatment and Surveillance
Thomsen, W. C., Maese, L. D., Vagher, J., Moore, K. R., Cheshier, S. H., Hofmann, J. W., & Bruggers, C. S. (2021) · JCO Precision Oncology · doi:10.1200/po.20.00323 · Cited by 4
Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis
Zheng, C., Wang, Y., Luo, Y., Pang, Z.-G., Zhou, Y., Min, L., & Tu, C. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05020-6 · Cited by 4
Germline genomic findings in children and young adults with melanocytic tumors
Nagel, M. B., Perrino, M. R., Nuccio, R., Blake, A., Harrison, L. W., Nichols, K. E., & Pappo, A. S. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30361 · Cited by 4
Self-citation
GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE
Fabozzi, F., & Mastronuzzi, A. (2023) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2023.032 · Cited by 5
First report of medulloblastoma in a patient with MUTYH ‐associated polyposis
Villy, M., Warcoin, M., Filser, M., Buecher, B., Golmard, L., Suybeng, V., Schwartz, M., Bièche, I., Vacher, S., Laurence, V., et al. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12929 · Cited by 4
Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia
Fabozzi, F., Carrozzo, R., Lodi, M., Giannatale, A. D., Cipri, S., Rosignoli, C., Giovannoni, I., Stracuzzi, A., Rizza, T., Montante, C., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1324013 · Cited by 4
Clinical applicability of proposed algorithm for identifying individuals at risk for hereditary hematologic malignancies
Clifford, M., Bannon, S. A., Bednar, E. M., Czerwinski, J. L., Davis, J., Dunnington, L. A., Hashmi, S. S., & Dinardo, C. D. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1630618 · Cited by 4
PTPRD copy number variants and Ewing's sarcoma: Strengthening the association and therapeutic implications
Saskin, A., Seath, K., Tihy, F., Lemyre, E., Davis, J. H., Halal, F., & Armstrong, L. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.03.004 · Cited by 4
Increased Cancer Risk in Families with Pediatric Cancer Is Associated with Gender, Age, Diagnosis, and Degree of Relation to the Child
Stjernfelt, K.-J., von Stedingk, K., Wiebe, T., Hjorth, L., Kristoffersson, U., Stenmark‐Askmalm, M., Olsson, H. L., & Øra, I. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0322 · Cited by 4
Precision Medicine Search for Paediatric Oncology
Koopman, B., Wright, T., Omer, N., McCabe, V., & Zuccon, G. (2021) · International ACM SIGIR Conference on Research and Development in Information Retrieval (SIGIR) · doi:10.1145/3404835.3462792 · Cited by 4
Family history of early onset acute lymphoblastic leukemia is suggesting genetic associations
Li, X., Sundquist, K., Sundquist, J., Försti, A., & Hemminki, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-90542-7 · Cited by 4
Factors Affecting Genetic Consultation in Adolescent and Young Adult Patients With Sarcoma
McKay, G. E., Zakas, A. L., Osman, F., & Parkes, A. M. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.7034 · Cited by 4
An Investigation of Connections between Birth Defects and Cancers Arising in Adolescence and Very Young Adulthood
Behren, J. V., Fisher, P. G., Carmichael, S. L., Shaw, G. M., & Reynolds, P. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.02.057 · Cited by 4
Next generation sequencing and anti-cancer therapy
Sohn, J. (2019) · Journal of Korean Medical Association · doi:10.5124/jkma.2019.62.2.119 · Cited by 4
Genetic Predisposition to Non-Hodgkin Lymphoma
Haas, O. A., & Borkhardt, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-11769-6_8 · Cited by 4
Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative
Gargallo, P., de Mora, J. F., Berlanga, P., Calabria, I., Llavador, M., Pedrola, L., Panadero, J., Dolz, S., Zúñiga, Á., Oltra, J. S., et al. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0042-7 · Cited by 4
The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient
Li, Y., Li, T., Tang, Y., Zhan, Z., Ding, L., Song, L., Yu, T., Yang, Y., Ma, J., Zhang, Y., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234262 · Cited by 4
Self-citation
Acute Lymphoblastic Leukemia
Pui, C. (2015) · Springer eBooks · doi:10.1007/978-3-642-27841-9_57-5 · Cited by 4
Self-citation
Navigating Precision Oncology: Insights from an Integrated Clinical Data and Biobank Repository Initiative across a Network Cancer Program
Aryal, B., Bizhanova, Z., Joseph, E. A., Yin, Y., Wagner, P. L., Dalton, E., LaFramboise, W. A., Bartlett, D. L., & Allen, C. J. (2024) · Cancers · doi:10.3390/cancers16040760 · Cited by 3
Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC
Wang, A., Wang, C., Li, W., Qiao, J., Luo, Y., & Tian, Y. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05694-6 · Cited by 3
Missed opportunities: Germline testing following tumor sequencing
Karpel, H. C., Sasse, S. A., & Pothuri, B. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.06.011 · Cited by 3
Challenges in identifying paediatric cancer predisposition syndromes: international SCOPE survey and SIOPE expert consensus recommendations
Pavić, J. Ć., Cullinan, N. M., Jongmans, M. C. J., Bourdeaut, F., Wadt, K., LoNigro, L., Davies, M., Michaeli, O., Strang‐Karlsson, S., Putter, R. D., et al. (2026) · European Journal of Human Genetics · doi:10.1038/s41431-026-02040-x · Cited by 3
Seltene Tumordispositionssyndrome mit Manifestation im Kindesalter
Ripperger, T., Wimmer, K., & Kratz, C. P. (2017) · Medizinische Genetik · doi:10.1007/s11825-017-0150-6 · Cited by 3
Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer
Derpoorter, C., Paemel, R. V., Vandemeulebroecke, K., Vanhooren, J., Wilde, B. D., Laureys, G., & Lammens, T. (2022) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2022.2101723 · Cited by 3
Late health effects and changes in lifestyle factors after cancer in childhood with and without subsequent second primary cancers – the KiKme case-control study
Brackmann, L. K., Foraita, R., Schwarz, H., Galetzka, D., Zahnreich, S., Hankeln, T., Löbrich, M., Poplawski, A., Grabow, D., Blettner, M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1037276 · Cited by 3
Combinatorial batching of DNA for ultralow-cost detection of pathogenic variants
Stoltze, U. K., Hagen, C. M., Hansen, T. V. O., Byrjalsen, A., Gerdes, A., Yakimov, V., Rasmussen, S., Bækvad‐Hansen, M., HOUGAARD, D. M., Schmiegelow, K., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01167-6 · Cited by 3
Advanced colon cancer coexisting with multiple Osteochondromatosis in a child; coincidence or causality? - A case report
Calas, R. A. R., Millán, T. G., Mohammed, S., Leal, G. A., Amadu, M., & Seidu, A. S. (2023) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2023.108427 · Cited by 3
Cancer Prevalence in Children with Inborn Errors of Immunity: Report from a Single Institution
Mitchell, M. R., Urdinez, L., Bernasconi, A. R., Danielian, S., Katsikas, M., Sajaroff, E. O., Roffé, G., Villa, N. M., Galluzzo, L., Sanz, M., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01736-3 · Cited by 3
Playing Russian Roulette: Parent and Adolescent Perspectives on Tumor Surveillance for Adolescents with Cancer Predisposition Syndromes
Elias, R., Blake, A. K., Dean, L. W., Flynn, J. S., Sachner, L., Harrison, L. H., McGee, R. B., Nichols, K. E., & Sharp, K. M. H. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0693 · Cited by 3
Self-citation
Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study
Westerveld, A. S. R., Tytgat, G. A. M., van Santen, H. M., van Noesel, M. M., Loonen, J. J., de Vries, A., Louwerens, M., Koopman, M. M. W., der Loo, M. V. D. H., Janssens, G. O. R. J., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.01430 · Cited by 3
The relative contributions of genetic and non‐genetic factors to the risk of neuroblastoma
Jung, E. M., Heck, J. E., & Spector, L. G. (2024) · Pediatric Investigation · doi:10.1002/ped4.12455 · Cited by 3
Proximity Proteomics Reveals USP44 Forms a Complex with BRCA2 in Neuroblastoma Cells and Is Required to Prevent Chromosome Breakage
Ali, A., Hussain, S., Bedekovics, T., Jeon, R. H., May, D. G., Roux, K. J., & Galardy, P. J. (2024) · Biomedicines · doi:10.3390/biomedicines12122901 · Cited by 3
Prognostic importance of direct assignment of parent of origin via long-read genome and epigenome sequencing in retinoblastoma
Stacey, A. W., Nakamichi, K., Huey, J., Stevens, J., Waligorski, N., Crotty, E. E., Gelder, R. N. V., & Mustafi, D. (2024) · JCI Insight · doi:10.1172/jci.insight.188216 · Cited by 3
Comprehensive Genomic Characterization of Congenital and Infantile Cancers Reveals High Yield of Medically Meaningful Findings
Mathew, M. T., Potter, S. L. P., Schieffer, K. M., O’Donovan, J., Garfinkle, E. A. R., Paxton, S. A., Setty, B. A., Lazow, M., Boué, D. R., Varga, E., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00910 · Cited by 3
Self-citation
Heritable cancer: Rounding up the not so usual suspects
Lipton, J. M. M., & Alter, B. P. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26190 · Cited by 3
An update on the central nervous system manifestations of familial tumor predisposition syndromes
Solomon, D. A. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02130-0 · Cited by 3
Genitourinary manifestations of hereditary cancer predisposition syndromes in children
Gillespie, N. J., & Mater, D. V. (2020) · Translational Andrology and Urology · doi:10.21037/tau-2019-pum-09 · Cited by 3
“Somatic” Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer
Knapp, E. E. (2020) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110520979389 · Cited by 3
Clinical practice of a genetics referral selection tool in pediatric cancer patients
Demırsoy, U., & Corapcioglu, F. V. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104167 · Cited by 3
Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)
Gargallo, P., Bautista, F. J., Ribelles, A. J., Izquierdo, E., Soriano, A., de Rojas, T., Escudero, A., Lavarino, C. E., Solano, P., Hladun, R., et al. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02759-7 · Cited by 3
Genome-wide association study of posttraumatic stress disorder among childhood cancer survivors: results from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort
Lu, D., Sapkota, Y., Valdimarsdóttir, U. A., Koenen, K. C., Li, N., Leisenring, W. M., Gibson, T. M., Wilson, C. L., Robison, L. L., Hudson, M. M., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02110-w · Cited by 4
Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients’ relatives
Alanen, E., Heikkinen, S. M. M., Nurminen, R., Nykter, M., Haapasalo, H. K., Hirvonen, E. M., Pitkäniemi, J. M., & Rautajoki, K. J. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad008 · Cited by 3
Lessons learnt from the clinico-genomic profiling of families with Li Fraumeni syndrome at a tertiary care centre in North India
Tansir, G., Rastogi, S., Dubasi, S., Chitikela, S., Lavu, R. R., Barwad, A. W., & Goyal, A. (2023) · ecancermedicalscience · doi:10.3332/ecancer.2023.1550 · Cited by 3
Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States
Roy, B., Knapke, S. C., Pillay‐Smiley, N., Zhang, X., Queen, K., & Sisson, R. A. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30725 · Cited by 3
Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology
Jacobs, M. F., Goldman, J. W., Austin, S., Koeppe, E. S., Murad, A. M., Koschmann, C. J., Chinnaiyan, A. M., & Mody, R. J. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00539 · Cited by 3
Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review
Freyçon, C., Sépulchre, E., Lavallée, V., Mitchell, D., MacMillan, M. L., Vézina, C., & Goudie, C. (2024) · Clinical Genetics · doi:10.1111/cge.14537 · Cited by 3
Radiolabeling and preclinical animal model evaluation of DTPA coupled 99m Tc-labelled flutamide complex ([ 99m Tc]DTPA-FLUT) as a potential radiotracer for cancer imaging
Naqvi, S. A. R., Hassan, A. J., Janjua, M. R. S. A., Abbas, N., Zahoor, A. F., Hassan, S. U., & Hussain, A. (2024) · Acta Radiologica · doi:10.1177/02841851241249161 · Cited by 3
Integrated gene-metabolite association network analysis reveals key metabolic pathways in gastric adenocarcinoma
Xu, B., Shi, Y., Yuan, C., Wang, Z., Chen, Q., Wang, C., & Chai, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37156 · Cited by 3
Atypical presentations of RECQL4‐related syndromes
Grossmann, L. D., Baldino, S. E., Zelley, K., Balis, F. M., Bagatell, R., Kalish, J. M., & MacFarland, S. P. (2024) · Pediatric Blood & Cancer · doi:10.1002/pbc.31315 · Cited by 3
Exploring germline variants in genes associated with inborn errors of immunity and inherited bone marrow failure syndromes in pediatric hematological malignancies
Bakhuizen, J. J., van Dijk, F., Bon, S. B. B., van der Veken, L. T., Huibers, M. M. H., van Montfrans, J. M., Bruyne, M. D., Moerloose, B. D., Haerynck, F., Loeffen, J. L. C., et al. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115598 · Cited by 2
Inherited Risk for Childhood Leukemia
Vagher, J., Maese, L. D., Gammon, A., Kohlmann, W. K., & Schiffman, J. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-74448-9_11 · Cited by 3
Options of precision medicine in pediatric oncology: literature review
Dinikina, Y. V., & Belogurova, M. B. (2022) · Russian Journal of Pediatric Hematology and Oncology · doi:10.21682/2311-1267-2021-8-4-71-80 · Cited by 3
Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms
Shih, A., Jun, T. W., Skol, A. D., Bao, R., Huang, L., Vora, S., McNerney, M. E., Hungate, E. A., Beau, M. M. L., Larson, R. A., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18543 · Cited by 3
Galileo in Bethesda: The future of gene editing
Grouse, L. D. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0014 · Cited by 3
Kindliche Hirntumoren
Reith, W., Bodea, S., & Mühl‐Benninghaus, R. (2017) · Der Radiologe · doi:10.1007/s00117-017-0287-y · Cited by 3
Genetic predisposition to medulloblastomas: just follow the tumour genome
Bourdeaut, F., & Delattre, O. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30289-4 · Cited by 3
CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia
Ding, C., Huang, Y., Shi, M., Nie, B., Li, Y., Wu, K., Yang, J., & Zeng, Y. (2019) · Medicine · doi:10.1097/md.0000000000015204 · Cited by 3
Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations
Sprissler, R. S., Perkins, B., Johnstone, L. M., Babiker, H. M., Chalasani, P., Lau, B., Hammer, M. F., & Mahadevan, D. (2020) · Cancers · doi:10.3390/cancers12061618 · Cited by 3
A deep analysis using panel-based next-generation sequencing in an Ecuadorian pediatric patient with anaplastic astrocytoma: a case report
García-Cárdenas, J. M., Zambrano, A. K., Guevara‐Ramírez, P., Guerrero, S. X., Runruil, G., López‐Cortés, A., Torres-Yaguana, J. P., Armendáriz‐Castillo, I., Pérez‐Villa, A., Yumiceba, V., et al. (2020) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02451-4 · Cited by 3
CANCER INCIDENCE AND MORTALITY IN CHILDREN AND ADOLESCENTS IN PRIMORSKY KRAI FOR THE 2008–2018 PERIOD
Минкина, Л. М., Tsvetkov, M. M., Tikhonova, Y. S., & Postoykina, M. A. (2020) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2020-19-6-19-27 · Cited by 3
The Epidemiology of Cancer in Children and Adolescents
Stiller, C. A., & Gatta, G. (2020) · doi:10.1093/med/9780198797210.003.0001 · Cited by 3
What Every Neuropathologist Needs to Know: Practical Aspects and Pitfalls in Molecular Diagnosis of Brain Tumors
Nix, J. S., & Ida, C. M. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab033 · Cited by 3
Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia
Aleem, A., Haque, A. R., Roloff, G. W., & Griffiths, E. A. (2021) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-021-00641-5 · Cited by 4
Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer
Alba‐Pavón, P., Alaña, L., Astigarraga, I., & Villate, O. (2022) · Cancers · doi:10.3390/cancers14235967 · Cited by 3
The Epidemiology and Pathogenesis of Sarcoma
Kabir, W., & Choong, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-9414-4_2 · Cited by 3
Genetic panels in young patients with bone marrow failure: are they clinically relevant?
Dezern, A. E., & Brodsky, R. A. (2016) · Haematologica · doi:10.3324/haematol.2016.152389 · Cited by 3
Genomic Strategies for Personalized Cancer Therapy
Dudek, A. Z., Baxstrom, K., Bharadwaj, S., Blaes, A. H., Kulkarni, A. A., Lou, E., Nehru, V. M., Rabinovich, E., Shergill, A. P., & Viner, M. (2020) · Wiley eBooks · doi:10.1002/9781119432487.ch1 · Cited by 3
Risk Factors for Malignancies in Pediatric Population: Results of A Population-Based Case-Control StudyPreprint
Saab, Y. B., Naccache, M., Zeenny, R. M., Nabhani‐Gebara, S., & Sholy, L. (2021) · Research Square · doi:10.21203/rs.3.rs-271529/v1 · Cited by 3
Molecular Alterations in Pediatric Solid Tumors
Slack, J. C., & Church, A. J. (2024) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2023.08.012 · Cited by 3
Assessment of cancer predisposition syndromes in children with leukemia and solid tumors: germline-genomic profiling and clinical features in a series of cases
Singh, M., Bhatia, P., Sharma, P. K., Trehan, A., & Jain, R. (2024) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2024.2411321 · Cited by 2
Genomic Sequencing in Pediatric Oncology: Perspectives of Parents and Adolescents on Ethical Issues
Knapp, E. E., Hall, J., Middleton, A. A., Rich, C. A., & Brothers, K. B. (2025) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000003048 · Cited by 2
Pediatric Cancer Genetics and Genomics
Mardis, E. R. (2025) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120823-010156 · Cited by 4
Self-citation
Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective
Basquiera, A. L., Andreoli, V., Grille, S., & Belli, C. (2025) · Genes · doi:10.3390/genes16060687 · Cited by 2
Nano optical (bio)sensing platforms for early detection of pediatric cancer
Hsu, C., Kumar, A., Kanjariya, P., Rajiv, A., Kashyap, A., Albert, H. M., Pokhriyal, S., & Panigrahi, R. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07246-2 · Cited by 2
Contribution of Germline Predisposition to Pediatric Thyroid Cancer
Harrison, C., Blake, A. K., Su, Y., Tang, L., Oak, N., Harrison, L. H., Nuccio, R., McGee, R. B., Grieve, L. M., Pandey, A. S., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0631 · Cited by 2
Self-citation
Utility of Germline, Somatic and ctDNA Testing in Adults With Cancer
DeBortoli, E., McGahan, E., Yanes, T., Berkman, J. L., Aoude, L. G., Smit, A. K., Gokoolparsadh, A., Hermes, A., Newett, L., Bourke, M., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.71080 · Cited by 4
Rate of germline pathogenic sequence variants in cancer susceptibility genes in an Israeli pediatric and adolescent cancer cohort: a single institute experience
Nahom, D., Frenkel, Z., Toren, A., Friedman, E., & Kventsel, I. (2025) · Familial Cancer · doi:10.1007/s10689-025-00489-1 · Cited by 2
Germline rare variants in cancer susceptibility genes and subsequent neoplasm risk after childhood cancer
Zamani, S. A., Karyadi, D. M., Hartley, S. W., Gibson, T. M., Sampson, J. N., Kraft, P., Chanock, S. J., & Morton, L. M. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf260 · Cited by 2
Enhanced detection and characterization of germline structural variants in cancer predisposition genes via genome sequencing
Kargaran, P. K., Ding, Q., Choate, L. A., Sellers, H. L., Stein, M. I., Moyers, B. A., Basu, S., Tandale, P. P., Setlem, R., Bishop, M. F., et al. (2025) · Genetics in Medicine Open · doi:10.1016/j.gimo.2025.103459 · Cited by 2
Late Effects in Survivors of Pediatric Medulloblastoma: A Comprehensive Review
Izurieta‐Pacheco, A. C., Ramaswamy, V., Tsang, D. S., Rutka, J. T., Wasserman, J. D., Guger, S., Weidman, D. R., Nathan, P. C., Scheinemann, K., & Bennett, J. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.32132 · Cited by 3
Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition Genes
Jacobs, M. F., Austin, S., Murad, A. M., Koeppe, E. S., Kumar‐Sinha, C., Robinson, D. R., Wu, Y.-M., Vo, J. N., Koschmann, C. J., Robertson, P. L., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00749 · Cited by 2
Development and pilot testing of AYA-RISE, a risk information and screening education intervention for adolescents and young adults with cancer risk syndromes
Kamihara, J., Fisher, L., Schienda, J., Vanderwall, R., Snir, M., Snir, G., Simmons, E., Khalaj, A., Goler, E., Hamilton, K. V., et al. (2026) · Familial Cancer · doi:10.1007/s10689-025-00525-0 · Cited by 2
Therapy-Related Mutational Signatures in Subsequent Neoplasms among Survivors of Childhood Cancer
Brady, S. W., Arnold, M., Wang, M., Alsallaq, R. A., Dong, L., Khan, M. A., Yang, W., Stratton, K. L., Liu, W., Chen, Y., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0231 · Cited by 2
Self-citation
Genetics and Genomics: Precision Health in Pediatric Oncology
Mandrell, B. N., Hines‐Dowell, S. J., & Nishigaki, M. (2020) · Pediatric oncology · doi:10.1007/978-3-030-25804-7_13 · Cited by 2
Self-citation
Childhood central nervous system tumors and leukemia: Incidence and familial risk. A comparative population‐based study in Utah and Norway
Kollerud, R. D. R., Cannon‐Albright, L., Haugnes, H. S., Ruud, E., Thoresen, M., Nafstad, P. H. J., Blaasaas, K. G., Næss, Ø., & Claussen, B. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28408 · Cited by 2
The Role of Genetic Mutations in the Prevention of Malignant Tumours in a Healthy Population (A Review)
Lipatov, O. N., & Тагировна, А. К. (2021) · Creative Surgery and Oncology · doi:10.24060/2076-3093-2020-10-4-330-338 · Cited by 2
A Novel Germline Compound Heterozygous Mutation of BRCA2 Gene Associated With Familial Peripheral Neuroblastic Tumors in Two Siblings
Yang, Y., Chen, J., Qin, H., Jin, Y., Zhang, L., Shen, Y., Wang, H., Fu, L., Hong, E., Yu, Y., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.652718 · Cited by 2
Mesenchymal, Fibroosseous, and Cartilaginous Orbital Tumors
Lane, K. A., Bilyk, J. R., & Jakobiec, F. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_66 · Cited by 2
Li–Fraumeni Syndrome ☆
Michaeli, O., & Malkin, D. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.96122-1 · Cited by 2
Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies—A Review
Filipiuk, A., Kozakiewicz, A., Kośmider, K., Lejman, M., & Zawitkowska, J. (2022) · Cancers · doi:10.3390/cancers14153569 · Cited by 3
A Patient with Bone Fragility, Multiple Fractures, Osteosarcoma, and the Variant c.143A>G in the IFITM5 Gene: A Case Report
Pachajoa, H., & Giraldo-Ocampo, S. (2022) · Orthopedic Research and Reviews · doi:10.2147/orr.s385146 · Cited by 2

Authors: Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., Wilkinson, M. R., Vadodaria, B., Chen, X., McGee, R. B., Hines-Dowell, S., Nuccio, R., Quinn, E., Shurtleff, S. A., Rusch, M., Patel, A., Becksfort, J. B., Wang, S., Weaver, M. S., Ding, L., Mardis, E. R., Wilson, R. K., Gajjar, A., Ellison, D. W., Pappo, A. S., Pui, C.-H., Nichols, K. E., & Downing, J. R.
Affiliations: St. Jude Children's Research Hospital (US)
Washington University in St. Louis (US)
ORCID: Zhang, Jinghui
Walsh, Michael F.
Wu, Gang
Edmonson, Michael N.
Gruber, Tanja A.
Easton, John
Ma, Xiaotu
Zhou, Xin
Yergeau, Donald A.
Wilkinson, Mark R.
Chen, Xiang
McGee, Rose B.
Nuccio, Regina
Quinn, Emily
Rusch, Michael
Patel, Aman
Becksfort, Jared B.
Weaver, Meaghann S.
Ding, Li
Mardis, Elaine R.
Wilson, Richard K.
Gajjar, Amar
Ellison, David W.
Pappo, Alberto S.
Pui, Ching-Hon
Nichols, Kim E.
Downing, James R.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-12-10
Volume: 373
Issue: 24
Pages: 2336-2346
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1508054
PMC: PMC4734119
OpenAlex: W2303408208
Cited by: 1,345
References: 56
Citations by year: 2026: 90 · 2025: 113 · 2024: 151 · 2023: 132 · 2022: 134 · 2021: 161 · 2020: 141 · 2019: 122 · 2018: 113 · 2017: 101 · 2016: 76 · 2015: 5
FWCI: 67.59
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Cancer Institute (R01CA180006, CA21765, P30CA021765)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: germline mutations, cancer susceptibility genes, childhood cancer, children and adolescents, TP53, APC, BRCA2, neurofibromatosis type 1, PMS2, RB1, RUNX1, tumor suppressor, pathogenicity assessment, family history of cancer, genetic counseling, autism spectrum disorder
MeSH terms: Adolescent, Autistic Disorder, Child, Female, Genes, Dominant, Humans, Male, Neoplasms, Genome, Human, Sequence Analysis, DNA, Germ-Line Mutation, SEER Program, Genetic Predisposition to Disease, Genes, Neoplasm, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Germline Mutations in Predisposition Genes in Pediatric Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks